---
figid: PMC10523235__WJD-14-1369-g005
pmcid: PMC10523235
image_filename: WJD-14-1369-g005.jpg
figure_link: /pmc/articles/PMC10523235/figure/F5/
number: Figure 5
figure_title: ''
caption: 'Knock-down of XB130 accelerated wound healing in diabetic mice. A: Western
  blot analysis of XB130 protein expression in each group; B: Quantification of Western
  blot results; C: Representative skin wound images from control and model mice at
  day 0 d, 7 d, 14 d, control (n = 10), model (n = 10), Vector (n = 10), and XB130-KD
  (n = 10); D: HE and Masson staining of skin wound in each group. aP < 0.001, compared
  to the Control group; bP < 0.01, compared to the Vector group.'
article_title: XB130 inhibits healing of diabetic skin ulcers through the PI3K/Akt
  signalling pathway.
citation: Xin-Lin Zhu, et al. World J Diabetes. 2023 Sep 15;14(9):1369-1384.
year: '2023'

doi: 10.4239/wjd.v14.i9.1369
journal_title: World Journal of Diabetes
journal_nlm_ta: World J Diabetes
publisher_name: Baishideng Publishing Group Inc

keywords:
- XB130
- Diabetes mellitus
- Diabetic skin ulcers
- PI3K/Akt signalling pathway

---
